vimarsana.com

Starna Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The biggest Asia-Pacific biotech investments in May 2022

Healthcare-focused biotech companies won the biggest private investments in the Asia-Pacific region in May 2022, led by a $100 million Series A from the Chinese anti-inflammatory drug developer Reistone Biopharma.

New zealandHong kongYuanneng bioElena reskoReistone biopharmaLaekna therapeuticsFull life technologiesStarna therapeuticsAnkere therapeuticsInsilico medicine

China Digest: Genfine Biotech nets $15m; Starna Therapeutics snags $10m

Genfine Biotech (Beijing) and Starna Therapeutics have raised funding.

Genfine biotech beijing co ltdChina merchants group securitiesChangping technology industrial parkGenfine biotechStarna therapeuticsChina merchants groupChina merchants securitiesChina merchants securities capitalBeijing changping technology industrial parkLegend capitalSequoia capital chinaSherpa healthcare partners

vimarsana © 2020. All Rights Reserved.